Feeds › Capitol Hires
Capitol Hires
Lobbyists whose filings say they once worked in a member of Congress' office, on a committee or in the executive branch, with the public company that hired them.
About this data
- What it is
- Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
- Who files it
- The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
- How current
- New filings are posted every day. We read each one the day after it is posted.
- Terms
- Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
- Worth knowing
- Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.
All of this comes from lobbying disclosure filings that the Senate and the House publish.
Information, not investment advice (disclaimer). Where this data comes from.
Latest Capitol Hires
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Paul Brathwaite | Department of Labor Executive branch | Chief of Staff, ESA | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Paul Brathwaite | Labor Executive branch | Special Assistant, U.S. Secretary of , Department of Labor | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Ven Neralla | Andy Levin Member office · Democrat-MI | Chief of Staff | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Ven Neralla | Pramila Jayapal Member office · Democrat-WA | Deputy Chief of Staff | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Ven Neralla | Barbara Lee Member office · Democrat-CA | Legislative Director | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Ven Neralla | Peter A. DeFazio Member office · Democrat-OR | Legislative Assistant | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Ven Neralla | USDA Executive branch | Senior Advisor | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Stacey Leavandosky | Zoe Lofgren Member office · Democrat-CA | Chief of Staff | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Stacey Leavandosky | Committee on Science Committee | Senior Advisor, , Space & Technology | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Stacey Leavandosky | Committee on House Administration Committee | Senior Advisor | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Wallace Kaade | Amy Klobuchar Member office · Democrat-MN | Legislative Correspondent | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Wallace Kaade | Betty McCollum Member office · Democrat-MN | Staff Assistant | Federal Street Strategies, LLC | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Monica Popp | John Cornyn Member office · Republican-TX | Chief of Staff/Deputy Chief of Staff | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| BMY Bristol-Myers Squibb Company | Monica Popp | Commerce Committee Committee | Professional Staff Member, U.S. House of Representatives-Energy | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| BMY Bristol-Myers Squibb Company | Monica Popp | Jim DeMint Member office · Republican-SC | Legislative Assistant | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| BMY Bristol-Myers Squibb Company | Hazen Marshall | Mitch McConnell Member office · Republican-KY | Policy Director | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| BMY Bristol-Myers Squibb Company | Hazen Marshall | Senate Budget Committee Committee | Staff Director | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| BMY Bristol-Myers Squibb Company | Hazen Marshall | Don Nickles (Senate) Member office · Senate | Legislative Assistant | Marshall & Popp, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 4 filings |
| BMY Bristol-Myers Squibb Company | Ann Jablon | Richard E. Neal Member office · Democrat-MA | Executive/ Legislative Assistant | Capitol Counsel LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| BMY Bristol-Myers Squibb Company | Christopher Wilcox | Arcuri (House) Member office · House | LA, Leg Counsel, LD & Counsel | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 3 filings |
| BMY Bristol-Myers Squibb Company | Christopher Wilcox | Demings (House) Member office · House | LD & Counsel | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 3 filings |
| BMY Bristol-Myers Squibb Company | Jeanne Haggerty | Senator Chuck Grassley and Senate Aging Committee Committee | Legislative Correspondent (shared staff), Legislative Aide , Health Policy Coordinator Energy and Commerce, Professional Staff Member | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Jeanne Haggerty | Senate Finance Committee Committee | Legislative Correspondent (shared staff), Legislative Aide , Health Policy Coordinator Energy and Commerce, Professional Staff Member | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Jeanne Haggerty | Health Subcommittee Committee | Legislative Correspondent (shared staff), Legislative Aide , Health Policy Coordinator Energy and Commerce, Professional Staff Member | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Robert Butora | Bill Cassidy Member office · Republican-LA | Health Policy Advisor | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Robert Butora | Leonard Lance Member office · Republican-NJ | Senior Health Policy Advisor | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Robert Butora | Michael C. Burgess Member office · Republican-TX | Health Legislative Assistant | Williams and Jensen, PLLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Amy Jensen | Office of the President Executive branch · 2003–2005 | Special Assistant to the President for Special Affairs | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 7 filings |
| BMY Bristol-Myers Squibb Company | Sarah Egge | Bob Kerrey (Senate) Member office · Senate · 1998–2000 | Sarah: Legislative Assistant | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Sarah Egge | Senate Budget Committee Committee · 2001–2012 | Senior Budget Analyst for Democratic Staff | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Sarah Egge | Kent Conrad Member office · Democrat-ND · 2001–2012 | Senior Budget Analyst for Democratic Staff | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Sarah Egge | Joint Select Committee for Deficit Reduction Committee | Deputy Staff Director | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 6 filings |
| BMY Bristol-Myers Squibb Company | Arielle Woronoff | Sandy Levin (House) Member office · House · 2012–2014 | Arielle: Counsel | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| BMY Bristol-Myers Squibb Company | Arielle Woronoff | Cory A. Booker Member office · Democrat-NJ · 2014–2015 | Leg. Asst | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| BMY Bristol-Myers Squibb Company | Arielle Woronoff | House E&C Committee Committee · 2015–2017 | Health Counsel, , Pallone (1/ -3/ ) | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| BMY Bristol-Myers Squibb Company | Arielle Woronoff | Sen. Finance Cmte Committee · 2017–2021 | Sr. Health Counsel, , Wyden (3/ -2/ ) | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| BMY Bristol-Myers Squibb Company | Arielle Woronoff | CMS Executive branch | Dir. OL, Dep. Chief of Staff | Splitoak Strategies LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| BMY Bristol-Myers Squibb Company | Raissa Downs | HHS Executive branch | Dep. Asst. Sec. for Leg | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Raissa Downs | Sub. Cmte on Employment Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Raissa Downs | Sen. HELP Cmte Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Jennifer Young | HHS Executive branch | Dep. Asst. Sec. for Leg | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Jennifer Young | House Cmte on Ways and Means Committee | Not stated | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Jennifer Young | Sen. Cmte on Finance Committee | Not stated | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Emily Murry | Sub. Cmte on Health Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Emily Murry | W&M Cmte Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Emily Murry | McCarthy Member office | Policy Advisor | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Emily Murry | Study Cmte Committee | Professional Staff, Republican | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Emily Murry | Ken Calvert Member office · Republican-CA | Leg. Aid | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Emily Murry | Tom Price Member office · Republican-GA | Leg. Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| BMY Bristol-Myers Squibb Company | Peter Fise | Sen. Cmte on Finance Committee | Health Counsel for , Health Counsel | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
The newest 50 of 137 matching. Narrow them with the filters above.
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 5:19 PM EST.